Skip to main content
. 2022 May 30;7(8):1878–1886. doi: 10.1016/j.ekir.2022.05.024

Figure 1.

Figure 1

Changes in proteinuria and serum creatinine. Serum albumin and serum proteins in a cohort of 31 patients with primary FSGS in the 12 months after therapy with RTX. The line represents median values, the box IQRs, and the whiskers maximum and minimum values. FSGS, focal segmental glomerular sclerosis; IQR, interquartile range; RTX, rituximab.